Prior to deployment of coronavirus disease 2019 (COVID‐19) vaccines in the European
Union in 2021, a high vaccine uptake leading to an unprecedented volume of safety data …

Purpose: Well-designed observational postmarketing studies using real-world data (RWD)
are critical in supporting an evidence base and bolstering public confidence in vaccine …

Abstract Background The Global COVID Vaccine Safety (GCoVS) project was established in
2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate …

External factors severely affecting in a short period of time the spontaneous reporting of
adverse events (AEs) can significantly impact drug safety signal detection. Coronavirus …

We test the robustness of the self-controlled risk interval (SCRI) design in a setting where
time between doses may introduce time-varying confounding, using both negative control …

Introduction Vaccine pharmacovigilance is an essential component of vaccine safety
programs. Vaccine pharmacovigilance refers to detecting uncommon adverse events …

Purpose Heterogeneous results from multi‐database studies have been observed, for
example, in the context of generating background incidence rates (IRs) for adverse events of …

Purpose The generation of representative disease phenotypes is important for ensuring the
reliability of the findings of observational studies. The aim of this manuscript is to outline a …

Background Determining background rates of medical conditions identified as adverse
events of special interest (AESI) that may occur following COVID-19 vaccination is important …

Each cargo in a cell employs a unique set of motor proteins for its transport. To dissect the
roles of each type of motor, we developed optogenetic inhibitors of endogenous kinesin-1 …